Back to Trades
Total Value
$7.1K
Net $7.1K sold
Filing Date
Oct 3, 2025
1 transaction
Sales
$7.1K
1 transaction
Trade Summary
On Oct 2, 2025, Pham Quang X, CEO and Chairman, Director, 10% Owner, sold $7.1K of Cadrenal Therapeutics, Inc. (CVKD) across 1 transaction. The filing covers Common Stock and reflects net selling of $7.1K. Reported prices ranged from $14.13. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Cadrenal Therapeutics, Inc.
- Ticker Symbol
- CVKD
- CIK
- 0001937993
Insider Information
- Name
- Pham Quang X
- Role
- CEO and Chairman, Director, 10% Owner
- Location
- PONTE VEDRA, FL
Filing Details
- Filing Date
- Oct 3, 2025
- Transaction Date
- Oct 2, 2025
- Accession Number
- 0001213900-25-096241
- Form Type
- 4
- Net Trading Amount
- -$7.1K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Oct 2, 2025 | Common Stock | 500 | $14.13 | Sale | $7.1K |
Want live alerts when Pham Quang X trades again?
Download Insider Trades to track CVKD, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement in multiple transactions at prices ranging from $14.04 through $14.27, inclusive, having a weighted average price as shown in column 4 of $14.13. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- (F2)Quang Pham is the Trustee of The PVBQ Living Trust and has sole voting and disposition power with respect to the shares owned by The PVBQ Trust, of which Mr. Pham's child is the sole beneficiary.